Tomasz Janicki - Burzynski Research Vice President - Clinical Trials
BZYR Stock | USD 0.04 0.01 20.00% |
President
Dr. Tomasz Janicki, M.D., serves as Vice President Clinical Trials of the Company, since March 1, 2012. Dr. Janicki currently works at Burzynski Clinic. Dr. Janicki joined Burzynski Clinic in 1997 as Research Associate and has served as Director of Medical Documentation at Burzynski Clinic since 2002. Dr. Janicki was involved in the administrative oversight of the Research Department at Burzynski Clinic, and has coauthored 43 publications and presentations for the advancement and acceleration of research and clinical trials at Burzynski Clinic. Dr. Janicki received his M.D. degree from Medical University in Wroclaw, Poland. since 2012.
Age | 47 |
Tenure | 12 years |
Phone | 713 335 5697 |
Web | https://www.burzynskiclinic.com |
Burzynski Research Management Efficiency
The company has return on total asset (ROA) of (127.6631) % which means that it has lost $127.6631 on every $100 spent on assets. This is way below average. Burzynski Research's management efficiency ratios could be used to measure how well Burzynski Research manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Amy Rock | Cumberland Pharmaceuticals | N/A | |
Yuichi Tsujimoto | HUTCHMED DRC | 60 | |
John Deren | Teleflex Incorporated | N/A | |
Morio Sumiya | HUTCHMED DRC | 55 | |
Koji Sumioka | HUTCHMED DRC | 59 | |
Hiroshi Tokushige | HUTCHMED DRC | 64 | |
Steve Hightower | Presidio Property Trust | 56 | |
Karen Boylan | Teleflex Incorporated | 47 | |
James Ferguson | Teleflex Incorporated | N/A | |
Matthew James | Teleflex Incorporated | N/A | |
Cameron Hicks | Teleflex Incorporated | 59 | |
Roger Graham | Teleflex Incorporated | N/A | |
Thomas Powell | Teleflex Incorporated | 62 | |
James Leyden | Teleflex Incorporated | 52 | |
Mario Wijker | Teleflex Incorporated | 52 | |
Leo Pavliv | Cumberland Pharmaceuticals | 54 | |
Tadashi Motoi | HUTCHMED DRC | 56 | |
Praneet Mehrotra | Teleflex Incorporated | N/A |
Management Performance
Return On Asset | -127.66 |
Burzynski Research Leadership Team
Elected by the shareholders, the Burzynski Research's board of directors comprises two types of representatives: Burzynski Research inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Burzynski. The board's role is to monitor Burzynski Research's management team and ensure that shareholders' interests are well served. Burzynski Research's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Burzynski Research's outside directors are responsible for providing unbiased perspectives on the board's policies.
Patryk Goscianski, Treasurer, Secretary | ||
Tomasz Janicki, Vice President - Clinical Trials | ||
Barbara Burzynski, Director | ||
Carlton Hazlewood, Director | ||
Gregory Burzynski, Director | ||
Stanislaw Burzynski, Chairman of the Board and Presidentident |
Burzynski Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Burzynski Research a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -127.66 | |||
Current Valuation | 2.65 M | |||
Shares Outstanding | 131.45 M | |||
Shares Owned By Insiders | 81.00 % | |||
Price To Earning | (5.25) X | |||
Price To Book | 2,191 X | |||
EBITDA | (976.66 K) | |||
Net Income | (976.66 K) | |||
Cash And Equivalents | 1.27 K | |||
Current Ratio | 0.11 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Burzynski Research in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Burzynski Research's short interest history, or implied volatility extrapolated from Burzynski Research options trading.
Pair Trading with Burzynski Research
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burzynski Research position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will appreciate offsetting losses from the drop in the long position's value.Moving together with Burzynski Pink Sheet
0.72 | BA | Boeing Fiscal Quarter End 31st of March 2024 | PairCorr |
Moving against Burzynski Pink Sheet
0.81 | AXP | American Express Sell-off Trend | PairCorr |
0.81 | IBM | International Business Fiscal Quarter End 31st of March 2024 | PairCorr |
0.79 | DIS | Walt Disney Aggressive Push | PairCorr |
0.78 | TRV | The Travelers Companies Fiscal Quarter End 31st of March 2024 | PairCorr |
0.76 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
The ability to find closely correlated positions to Burzynski Research could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burzynski Research when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burzynski Research - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burzynski Research to buy it.
The correlation of Burzynski Research is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burzynski Research moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burzynski Research moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burzynski Research can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burzynski Research. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Burzynski Pink Sheet analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |